Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
Posts
- Category: Articles (continued)
- NC Universities, Medical Schools and Nonprofit Design Model to Improve Quality of Life with Huntington’s Disease
- Network methods for describing sample relationships in genomic datasets: application to Huntington's disease
- NEUROBIOLOGY OF DISEASE PUBLISHES ENCOURAGING PRECLINICAL RESULTS OF AFFIRIS’ ANTIBODY MAB C6-17 TO TREAT HUNTINGTON’S DISEASE
- Neurodegenerative Disease Management
- Neurogenetica: nuove terapie, intesa fondazione Montalcini-Cina
- NeuroPhage Discovers GAIM-changing Molecules to Combat Alzheimer’s Disease and Other Neurodegenerative Disorders
- Neurophage, Inc. Raises $6.4 Million In Additional Financing
- Neuroscience Professor Studies Environmental Influence in Huntington’s Disease
- NeuroSearch A/S reports conclusions from the Multiple Ascending Dose study (MAD) with Huntexil®
- Neurosearch denies share manipulation charges
- New 96-bed Good Samaritan Society - Specialty Care Community Opens in Robbinsdale, Minn
- New compound for slowing the aging process can lead to novel treatments for brain diseases
- New drug for Huntington’s disease to be tested in Vancouver
- New protocol developed to decontaminate human fetal tissues used for cell transplantation
- New studies hint at possible approaches to protect those at risk for Huntington's disease
- New test measures deadly protein in Huntington's disease patients' spinal fluid
- New therapeutic target identified for Huntington's disease
- New Therapies on the Horizon for Huntington's Disease
- New £9.1m contract with a top 10 global pharmaceutical company
- News from the Society for Neuroscience Annual Meeting: Gene Editing Techniques Show Promise in Silencing or Inhibiting the Mutant Huntington's Disease Gene
- NEWSHD.NET un'anno insieme
- NIH study advances understanding of movement control
- NOBEL PRIZE TO BRITON, JAPANESE FOR STEM CELL WORK
- Northwestern Medicine Launches Huntington's Disease Center
- NOTIZIARIO AICH - ROMA APRILE 2014
- Notiziario AICH - Roma Onlus Marzo-Aprile 2012
- NOTIZIARIO AICH ROMA DICEMBRE 2013
- NOTIZIARIO AICH – ROMA AGOSTO 2014
- Novartis receives US Food and Drug Administration (FDA) Orphan Drug Designation for branaplam (LMI070) in Huntington’s disease (HD)
- Novel Gene Therapy Drug for Huntington's Disease
- Novel PET Biomarker May Detect Early Huntington's
- Novel RNAi Therapy Silences Mutated Huntington's Disease Gene and Reduces Symptoms
- Novel type of cell death in Huntington's disease may lead to effective new therapies
- Novità per la cura della malattia di Huntington
- Numerate Trains Its Computer-Aided Drug Design Platform On Huntington's Disease
- Nuova sperimentazione del PBT2 prodotto dalla Prana Biotech per la malattia di Huntington: notizie importanti
- Nuovo farmaco per la Malattia di Huntington sarà testato a Vancouver.
- Nutritional supplement slows Huntington’s
- Nuvilex reports breakthrough in stem cell research
- NZ scientists turn skin into brain cells
- Omeros Announces Encouraging Data from Phase 1 Clinical Trial for PDE10 Program
- Omeros Announces Enrollment in Second Phase 2 Clinical Trial with OMS824
- Omeros Files Investigational New Drug Application for Lead Compound in PDE10 Program
- Omeros Reports Additional Positive Clinical Data for its Drug Candidate to Treat Cognitive Disorders
- Omeros Reports Additional Positive Data from its OMS824 Phase 2a Schizophrenia Clinical Trial
- Omeros Reports Additional Positive Phase 1 Clinical Data for OMS824 for the Treatment of Cognitive Disorders
- Omeros Reports Additional Positive Results from OMS824 Program
- Omeros Requests Fast Track Designation for OMS824 for the Treatment of Huntington's Disease
- Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
- On the Hunt for Huntington’s Disease Treatments in the New Millennium
Plugin by dagondesign.com
